A day after Bharat Biotech slammed Serum Institute of India's CEO Adar Poonawalla for his 'water' comment about some COVID-19 vaccines, both the vaccine makers on Tuesday jointly pledged for a......
After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech on Monday applied to the central drug regulator seeking emergency use authorisation for its COVID-19 vaccine......
Bharat Biotech's vaccine, whose emergency use approval before finishing final stage testing had triggered a row, has shown an 81 per cent efficacy in preventing symptomatic COVID-19 in an interim......
500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.Sohini Das reports. IMAGE: Union Health Minister Harsh Vardhan shows......
An expert panel of India's central drug authority on Saturday recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine Covaxin with certain......
Stocks of Oxford COVID-19 vaccine, Covishield, are likely to start moving out of Serum Institute of India's facility here on early Tuesday morning, days ahead of the nationwide inoculation drive,......